相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。An update on the CNS manifestations of neurofibromatosis type 2
Shannon Coy et al.
ACTA NEUROPATHOLOGICA (2020)
Inhibition of cyclin-dependent kinase 7 down-regulates yes-associated protein expression in mesothelioma cells
Jinbai Miao et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2020)
Functional Genomic Screen in Mesothelioma Reveals that Loss of Function of BRCA1-Associated Protein 1 Induces Chemoresistance to Ribonucleotide Reductase Inhibition
Agata Okonska et al.
MOLECULAR CANCER THERAPEUTICS (2020)
CRISPR Screening Identifies WEE1 as a Combination Target for Standard Chemotherapy in Malignant Pleural Mesothelioma
Duo Xu et al.
MOLECULAR CANCER THERAPEUTICS (2020)
Linking cancer transcriptional addictions by CDK7 to YAP/TAZ
Stefano Piccolo
GENES & DEVELOPMENT (2020)
MicroRNA-98 is a prognostic factor for asbestos-induced mesothelioma
Kihun Kim et al.
JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH-PART A-CURRENT ISSUES (2020)
Detection of TGF-β in pleural effusions for diagnosis and prognostic stratification of malignant pleural mesothelioma
Paul Stockhammer et al.
LUNG CANCER (2020)
Genetic alterations of malignant pleural mesothelioma: association with tumor heterogeneity and overall survival
Lisa Quetel et al.
MOLECULAR ONCOLOGY (2020)
Pan-cancer analysis of whole genomes
Peter J. Campbell et al.
NATURE (2020)
Manipulating microRNAs for the Treatment of Malignant Pleural Mesothelioma: Past, Present and Future
Glen Reid et al.
FRONTIERS IN ONCOLOGY (2020)
Antiangiogeneic Strategies in Mesothelioma
Anna K. Nowak et al.
FRONTIERS IN ONCOLOGY (2020)
The spatial regulation of condensin activity in chromosome condensation
Rebecca Lamothe et al.
GENES & DEVELOPMENT (2020)
Combined deletion of Bap1, Nf2, and Cdkn2ab causes rapid onset of malignant mesothelioma in mice
Jitendra Badhai et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2020)
WRN-Mutated Colorectal Cancer Is Characterized by a Distinct Genetic Phenotype
Kai Zimmer et al.
CANCERS (2020)
Inherited Genetic Mutations and Polymorphisms in Malignant Mesothelioma: A Comprehensive Review
Vasiliki Panou et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
EIF4G1andRANas Possible Drivers for Malignant Pleural Mesothelioma
Irene Dell'Anno et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Biological Mechanisms and Clinical Significance of BAP1 Mutations in Human Cancer
Michele Carbone et al.
CANCER DISCOVERY (2020)
The study on copy number alteration of clear cell renal cancer in Chinese population
Ning Zhang et al.
JOURNAL OF CANCER (2020)
Squamous cell transformation as a mechanism of acquired resistance to tyrosine kinase inhibitor in EGFR-mutated lung adenocarcinoma: a report of two cases
Hironori Uruga et al.
RESPIROLOGY CASE REPORTS (2020)
LOX family and ZFPM2 as novel diagnostic biomarkers for malignant pleural mesothelioma
Min-Kyu Kim et al.
BIOMARKER RESEARCH (2020)
The International Cancer Genome Consortium Data Portal
Junjun Zhang et al.
NATURE BIOTECHNOLOGY (2019)
Loss of BAP1 Results in Growth Inhibition and Enhances Mesenchymal-Epithelial Transition in Kidney Tumor Cells
Pengsheng Chen et al.
MOLECULAR & CELLULAR PROTEOMICS (2019)
Inherited predisposition to malignant mesothelioma and overall survival following platinum chemotherapy
Raffit Hassan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Expression of estrogen receptor beta (ERβ) and its prognostic value in pleural mesothelioma
Jeronimo Rafael Rodriguez-Cid et al.
JOURNAL OF THORACIC DISEASE (2019)
Mesothelioma: Scientific clues for prevention, diagnosis, and therapy
Michele Carbone et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2019)
Inactivation of Bap1 Cooperates with Losses of Nf2 and Cdkn2a to Drive the Development of Pleural Malignant Mesothelioma in Conditional Mouse Models
Anna-Mariya Kukuyan et al.
CANCER RESEARCH (2019)
MicroRNA Signatures in Malignant Pleural Mesothelioma Effusions
Kimberly A. Birnie et al.
DISEASE MARKERS (2019)
Emerging therapies in malignant pleural mesothelioma
Marika Cinausero et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2019)
Epithelial to Mesenchymal Transition in Human Mesothelial Cells Exposed to Asbestos Fibers: Role of TGF- as Mediator of Malignant Mesothelioma Development or Metastasis via EMT Event
Stefano Turini et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Clinical significance of serum DRAM1 mRNA, ARSA mRNA, hsa-miR-2053 and lncRNA-RP1-86D1.3 axis expression in malignant pleural mesothelioma
Marwa Matboli et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2019)
COSMIC: the Catalogue Of Somatic Mutations In Cancer
John G. Tate et al.
NUCLEIC ACIDS RESEARCH (2019)
A link between the fibroblast growth factor axis and the miR-16 family reveals potential new treatment combinations in mesothelioma
Karin Schelch et al.
MOLECULAR ONCOLOGY (2018)
Clinical evaluation of circulating miR-548a-3p and-20a expression in malignant pleural mesothelioma patients
Marwa Matboli et al.
BIOMARKERS IN MEDICINE (2018)
Mutations of key driver genes in colorectal cancer progression and metastasis
Dongdong Huang et al.
CANCER AND METASTASIS REVIEWS (2018)
In Silico and In Vitro Analyses of LncRNAs as Potential Regulators in the Transition from the Epithelioid to Sarcomatoid Histotype of Malignant Pleural Mesothelioma (MPM)
Anand S. Singh et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Noncoding RNA:RNA Regulatory Networks in Cancer
Jia Jia Chan et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
NF2/Merlin Inactivation and Potential Therapeutic Targets in Mesothelioma
Tatsuhiro Sato et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Secreted and Tissue miRNAs as Diagnosis Biomarkers of Malignant Pleural Mesothelioma
Vanessa Martinez-Rivera et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Inactivation of Tp53 and Pten drives rapid development of pleural and peritoneal malignant mesotheliomas
Eleonora Sementino et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2018)
Dysregulated Expression of the MicroRNA miR-137 and Its Target YBX1 Contribute to the Invasive Characteristics of Malignant Pleural Mesothelioma
Thomas G. Johnson et al.
JOURNAL OF THORACIC ONCOLOGY (2018)
Novel therapies for malignant pleural mesothelioma
Arnaud Scherpereel et al.
LANCET ONCOLOGY (2018)
Malignant cells from pleural fluids in malignant mesothelioma patients reveal novel mutations
Sophie Sneddon et al.
LUNG CANCER (2018)
Progress and challenges in Mesothelioma: From bench to bedside
Kevin G. Blyth et al.
RESPIRATORY MEDICINE (2018)
Immunohistochemically detectable metallothionein expression in malignant pleural mesotheliomas is strongly associated with early failure to platin-based chemotherapy
Fabian D. Mairinger et al.
Oncotarget (2018)
In vitro patient-derived 3D mesothelioma tumor organoids facilitate patient-centric therapeutic screening
Andrea R. Mazzocchi et al.
SCIENTIFIC REPORTS (2018)
Biomarkers in malignant pleural mesothelioma: current status and future directions
Tamkin Ahmadzada et al.
JOURNAL OF THORACIC DISEASE (2018)
Overexpressed genes in malignant pleural mesothelioma: implications in clinical management
Elisa Barone et al.
JOURNAL OF THORACIC DISEASE (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Frequency of Germline Mutations in Cancer Susceptibility Genes in Malignant Mesothelioma
Vasiliki Panou et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
BAP1 links metabolic regulation of ferroptosis to tumour suppression
Yilei Zhang et al.
NATURE CELL BIOLOGY (2018)
Inhibiting crosstalk between MET signaling and mitochondrial dynamics and morphology: a novel therapeutic approach for lung cancer and mesothelioma
Jiale Wang et al.
CANCER BIOLOGY & THERAPY (2018)
A Subset of Mesotheliomas With Improved Survival Occurring in Carriers of BAP1 and Other Germline Mutations
Sandra Pastorino et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
BAP1 regulates different mechanisms of cell death
El Bachir Affar et al.
CELL DEATH & DISEASE (2018)
Improved estimation of cancer dependencies from large-scale RNAi screens using model-based normalization and data integration
James M. McFarland et al.
NATURE COMMUNICATIONS (2018)
Integrative Molecular Characterization of Malignant Pleural Mesothelioma
Jutija Hmeljaki et al.
CANCER DISCOVERY (2018)
Chemical Profiling of Primary Mesothelioma Cultures Defines Subtypes with Different Expression Profiles and Clinical Responses
Laurel M. Schunselaar et al.
CLINICAL CANCER RESEARCH (2018)
Comprehensive Pharmacogenomic Profiling of Malignant Pleural Mesothelioma Identifies a Subgroup Sensitive to FGFR Inhibition
Josine M. Quispel-Janssen et al.
CLINICAL CANCER RESEARCH (2018)
Co-occurring Mutations of Tumor Suppressor Genes, LATS2 and NF2, in Malignant Pleural Mesothelioma
Robin Tranchant et al.
CLINICAL CANCER RESEARCH (2017)
Patient-Derived Xenograft Establishment from Human Malignant Pleural Mesothelioma
Licun Wu et al.
CLINICAL CANCER RESEARCH (2017)
Germline BAP1 Alterations in Familial Uveal Melanoma
Karan Rai et al.
GENES CHROMOSOMES & CANCER (2017)
Malignant Pleural Mesothelioma: State of the art and advanced cell therapy
Giorgio Facchetti et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2017)
Targeting YAP in malignant pleural mesothelioma
Wen-Qian Zhang et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2017)
Mesothelin promotes epithelial-tomesenchymal transition and tumorigenicity of human lung cancer and mesothelioma cells
Xiaoqing He et al.
MOLECULAR CANCER (2017)
BAP1 regulates IP3R3-mediated Ca2+ flux to mitochondria suppressing cell transformation
Angela Bononi et al.
NATURE (2017)
GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses
Zefang Tang et al.
NUCLEIC ACIDS RESEARCH (2017)
Turning back the Wheel: Inducing Mesenchymal to Epithelial Transition via Wilms Tumor 1 Knockdown in Human Mesothelioma Cell Lines to Influence Proliferation, Invasiveness, and Chemotaxis
Till Ploenes et al.
PATHOLOGY & ONCOLOGY RESEARCH (2017)
Large-scale copy number analysis reveals variations in genes not previously associated with malignant pleural mesothelioma
Marieke Hylebos et al.
ONCOTARGET (2017)
MAP2K1 Mutation in Colorectal Cancer Patients: Therapeutic Challenge Using Patient-Derived Tumor Cell Lines
J. E. Kim et al.
JOURNAL OF CANCER (2017)
Genotypic and Phenotypic Features of BAP1 Cancer Syndrome A Report of 8 New Families and Review of Cases in the Literature
Alexandra M. Haugh et al.
JAMA DERMATOLOGY (2017)
Transcriptomic Analysis of the Claudin Interactome in Malignant Pleural Mesothelioma: Evaluation of the Effect of Disease Phenotype, Asbestos Exposure, and CDKN2A Deletion Status
Erasmia Rouka et al.
FRONTIERS IN PHYSIOLOGY (2017)
Combined Inhibition of CDK4/6 and PI3K/AKT/mTOR Pathways Induces a Synergistic Anti-Tumor Effect in Malignant Pleural Mesothelioma Cells
Mara A. Bonelli et al.
NEOPLASIA (2017)
UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses
Darshan S. Chandrashekar et al.
NEOPLASIA (2017)
The Strange Case of CDK4/6 Inhibitors: Mechanisms, Resistance, and Combination Strategies
Erik S. Knudsen et al.
TRENDS IN CANCER (2017)
SFRP Tumour Suppressor Genes Are Potential Plasma-Based Epigenetic Biomarkers for Malignant Pleural Mesothelioma
Yuen Yee Cheng et al.
DISEASE MARKERS (2017)
Germline BAP1 mutations induce a Warburg effect
Angela Bononi et al.
CELL DEATH AND DIFFERENTIATION (2017)
Novel insights into mesothelioma biology and implications for therapy
Timothy A. Yap et al.
NATURE REVIEWS CANCER (2017)
Defining a Cancer Dependency Map
Aviad Tsherniak et al.
CELL (2017)
Whole exome sequencing of an asbestos-induced wild-type murine model of malignant mesothelioma
Sophie Sneddon et al.
BMC CANCER (2017)
Targeting the epigenome in malignant pleural mesothelioma
Kaitlin C. McLoughlin et al.
TRANSLATIONAL LUNG CANCER RESEARCH (2017)
Podoplanin promotes progression of malignant pleural mesothelioma by regulating motility and focus formation
Shinji Takeuchi et al.
CANCER SCIENCE (2017)
Somatic Ephrin Receptor Mutations Are Associated with Metastasis in Primary Colorectal Cancer
Lucy Mathot et al.
CANCER RESEARCH (2017)
Gender-Specific Molecular and Clinical Features Underlie Malignant Pleural Mesothelioma
Assunta De Rienzo et al.
CANCER RESEARCH (2016)
Mithramycin Depletes Specificity Protein 1 and Activates p53 to Mediate Senescence and Apoptosis of Malignant Pleural Mesothelioma Cells
Mahadev Rao et al.
CLINICAL CANCER RESEARCH (2016)
Driver Gene and Novel Mutations in Asbestos-Exposed Lung Adenocarcinoma and Malignant Mesothelioma Detected by Exome Sequencing
Satu Maki-Nevala et al.
LUNG (2016)
Minimal asbestos exposure in germline BAP1 heterozygous mice is associated with deregulated inflammatory response and increased risk of mesothelioma
A. Napolitano et al.
ONCOGENE (2016)
Current surgical strategies for malignant pleural mesothelioma
Teruhisa Takuwa et al.
SURGERY TODAY (2016)
Genome-wide analysis of abdominal and pleural malignant mesothelioma with DNA arrays reveals both common and distinct regions of copy number alteration
Alain C. Borczuk et al.
CANCER BIOLOGY & THERAPY (2016)
Bap1 Is a Bona Fide Tumor Suppressor: Genetic Evidence from Mouse Models Carrying Heterozygous Germline Bap1 Mutations
Yuwaraj Kadariya et al.
CANCER RESEARCH (2016)
Dual Chromatin and Cytoskeletal Remodeling by SETD2
In Young Park et al.
CELL (2016)
The resistance related to targeted therapy in malignant pleural mesothelioma: Why has not the target been hit yet?
Giuseppe Bronte et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2016)
Downregulation of thymidylate synthase by RNAi molecules enhances the antitumor effect of pemetrexed in an orthotopic malignant mesothelioma xenograft mouse model
Amr S. Abu Lila et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2016)
ZEB1 drives epithelial-to-mesenchymal transition in lung cancer
Jill E. Larsen et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Bevacizumab for newly diagnosed pleural mesothelioma in the Mesothelioma Avastin Cisplatin Pemetrexed Study (MAPS): a randomised, controlled, open-label, phase 3 trial
Gerard Zalcman et al.
LANCET (2016)
Genomic Landscape of Malignant Mesotheliomas
Shumei Kato et al.
MOLECULAR CANCER THERAPEUTICS (2016)
Comprehensive genomic analysis of malignant pleural mesothelioma identifies recurrent mutations, gene fusions and splicing alterations
Raphael Bueno et al.
NATURE GENETICS (2016)
Dasatinib modulates sensitivity to pemetrexed in malignant pleural mesothelioma cell lines
Valentina Monica et al.
ONCOTARGET (2016)
Mesothelioma in the United States: a Surveillance, Epidemiology, and End Results (SEER)-Medicare investigation of treatment patterns and overall survival
Jennifer L. Beebe-Dimmer et al.
CLINICAL EPIDEMIOLOGY (2016)
Genetics of breast cancer: a topic in evolution
S. Shiovitz et al.
ANNALS OF ONCOLOGY (2015)
Malignant pleural mesothelioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upaEuro
P. Baas et al.
ANNALS OF ONCOLOGY (2015)
The Molecular Biology of Spindle Assembly Checkpoint Signaling Dynamics
Andrea Musacchio
CURRENT BIOLOGY (2015)
Overexpression of activin-A and -B in malignant mesothelioma - Attenuated Smad3 signaling responses and ERK activation promote cell migration and invasive growth
Jenni A. Tamminen et al.
EXPERIMENTAL CELL RESEARCH (2015)
A Comprehensive Genome-Based Mutational Analysis by Next Generation Sequencing Technology in Patients With Malignant Pleural and Peritoneal Mesothelioma
G. Ugurluer et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2015)
High Incidence of Somatic BAP1 Alterations in Sporadic Malignant Mesothelioma
Masaki Nasu et al.
JOURNAL OF THORACIC ONCOLOGY (2015)
Targeted Next-Generation Sequencing of Cancer Genes in Advanced Stage Malignant Pleural Mesothelioma A Retrospective Study
Marco Lo Iacono et al.
JOURNAL OF THORACIC ONCOLOGY (2015)
Loss of BAP1 function leads to EZH2-dependent transformation
Lindsay M. LaFave et al.
NATURE MEDICINE (2015)
Identification and characterization of essential genes in the human genome
Tim Wang et al.
SCIENCE (2015)
The biological functions of miRNAs: lessons from in vivo studies
Joana A. Vidigal et al.
TRENDS IN CELL BIOLOGY (2015)
Whole-Exome Sequencing Reveals Frequent Genetic Alterations in BAP1, NF2, CDKN2A, and CUL1 in Malignant Pleural Mesothelioma
Guangwu Guo et al.
CANCER RESEARCH (2015)
Expression profiling stratifies mesothelioma tumors and signifies deregulation of spindle checkpoint pathway and microtubule network with therapeutic implications
M. B. Suraokar et al.
ANNALS OF ONCOLOGY (2014)
CD26-mediated regulation of periostin expression contributes to migration and invasion of malignant pleural mesothelioma cells
Eriko Komiya et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2014)
Regulation of proteolysis by human deubiquitinating enzymes
Ziad M. Eletr et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2014)
An RNAi-based screen reveals PLK1, CDK1 and NDC80 as potential therapeutic targets in malignant pleural mesothelioma
A. Linton et al.
BRITISH JOURNAL OF CANCER (2014)
Multipoint targeting of the PI3K/mTOR pathway in mesothelioma
S. Zhou et al.
BRITISH JOURNAL OF CANCER (2014)
Germline Mutation of Bap1 Accelerates Development of Asbestos-Induced Malignant Mesothelioma
Jinfei Xu et al.
CANCER RESEARCH (2014)
Molecular Classification of Malignant Pleural Mesothelioma: Identification of a Poor Prognosis Subgroup Linked to the Epithelial-to-Mesenchymal Transition
Aurelien de Reynies et al.
CLINICAL CANCER RESEARCH (2014)
Overexpression and promoter mutation of the TERT gene in malignant pleural mesothelioma
A. Tallet et al.
ONCOGENE (2014)
Merlin Deficiency Predicts FAK Inhibitor Sensitivity: A Synthetic Lethal Relationship
Irina M. Shapiro et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Role of epidermal growth factor receptor in malignant pleural mesothelioma and its value for successful chemical pleurodesis
A. El-Hosainy et al.
EGYPTIAN JOURNAL OF CHEST DISEASES AND TUBERCULOSIS (2014)
Expression of snail, twist, and Zeb1 in malignant mesothelioma
Heta Merikallio et al.
APMIS (2013)
Mutation analysis of the EGFR gene and downstream signalling pathway in histologic samples of malignant pleural mesothelioma
R. Mezzapelle et al.
BRITISH JOURNAL OF CANCER (2013)
Overexpression of EPH Receptor B2 in Malignant Mesothelioma Correlates with Oncogenic Behavior
Chandra Goparaju et al.
JOURNAL OF THORACIC ONCOLOGY (2013)
Differential Expression of Extracellular Matrix Constituents and Cell Adhesion Molecules between Malignant Pleural Mesothelioma and Mesothelial Hyperplasia
Greta Ali et al.
JOURNAL OF THORACIC ONCOLOGY (2013)
The Wilms' tumor gene (WT1) regulates E-cadherin expression and migration of prostate cancer cells
Adina Brett et al.
MOLECULAR CANCER (2013)
RNA in unexpected places: long non-coding RNA functions in diverse cellular contexts
Sarah Geisler et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2013)
Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
Jianjiong Gao et al.
SCIENCE SIGNALING (2013)
PTEN protein expression in malignant pleural mesothelioma
Vijay Agarwal et al.
TUMOR BIOLOGY (2013)
Frequency of TERT promoter mutations in human cancers
Joao Vinagre et al.
NATURE COMMUNICATIONS (2013)
Identification of pregnancy-associated plasma protein A as a migration-promoting gene in malignant pleural mesothelioma cells: a potential therapeutic target
Jun Huang et al.
ONCOTARGET (2013)
Gremlin-1 associates with fibrillin microfibrils in vivo and regulates mesothelioma cell survival through transcription factor slug
J. A. Tamminen et al.
ONCOGENESIS (2013)
Transient but Not Stable ZEB1 Knockdown Dramatically Inhibits Growth of Malignant Pleural Mesothelioma Cells
Mihoko Horio et al.
ANNALS OF SURGICAL ONCOLOGY (2012)
Molecular Changes in Mesothelioma With an Impact on Prognosis and Treatment
Didier Jean et al.
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE (2012)
Data-driven information retrieval in heterogeneous collections of transcriptomics data links SIM2s to malignant pleural mesothelioma
Jose Caldas et al.
BIOINFORMATICS (2012)
Suppression of activin A signals inhibits growth of malignant pleural mesothelioma cells
M. A. Hoda et al.
BRITISH JOURNAL OF CANCER (2012)
Mapping the Hallmarks of Lung Adenocarcinoma with Massively Parallel Sequencing
Marcin Imielinski et al.
CELL (2012)
Mesothelin Overexpression Promotes Mesothelioma Cell Invasion and MMP-9 Secretion in an Orthotopic Mouse Model and in Epithelioid Pleural Mesothelioma Patients
Elliot L. Servais et al.
CLINICAL CANCER RESEARCH (2012)
Merlin: a tumour suppressor with functions at the cell cortex and in the nucleus
Wei Li et al.
EMBO REPORTS (2012)
Activated Leukocyte Cell-Adhesion Molecule (ALCAM) Promotes Malignant Phenotypes of Malignant Mesothelioma
Futoshi Ishiguro et al.
JOURNAL OF THORACIC ONCOLOGY (2012)
BAP1 cancer syndrome: malignant mesothelioma, uveal and cutaneous melanoma, and MBAITs
Michele Carbone et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2012)
Epithelial-mesenchymal transition in malignant mesothelioma
Ambrogio Fassina et al.
MODERN PATHOLOGY (2012)
Exploratory analysis of activation of PTEN-PI3K pathway and downstream proteins in malignant pleural mesothelioma (MPM)
S. Cedres et al.
LUNG CANCER (2012)
Landscape of transcription in human cells
Sarah Djebali et al.
NATURE (2012)
YAP induces malignant mesothelioma cell proliferation by upregulating transcription of cell cycle-promoting genes
T. Mizuno et al.
ONCOGENE (2012)
Germline BAP1 Inactivation Is Preferentially Associated with Metastatic Ocular Melanoma and Cutaneous-Ocular Melanoma Families
Ching-Ni Jenny Njauw et al.
PLOS ONE (2012)
The hallmarks of cancer A long non-coding RNA point of view
Tony Gutschner et al.
RNA BIOLOGY (2012)
The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data
Ethan Cerami et al.
CANCER DISCOVERY (2012)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
An Emerging Model for BAP1's Role in Regulating Cell Cycle Progression
Ziad M. Eletr et al.
CELL BIOCHEMISTRY AND BIOPHYSICS (2011)
The nuclear deubiquitinase BAP1 is commonly inactivated by somatic mutations and 3p21.1 losses in malignant pleural mesothelioma
Matthew Bott et al.
NATURE GENETICS (2011)
Germline BAP1 mutations predispose to malignant mesothelioma
Joseph R. Testa et al.
NATURE GENETICS (2011)
AXL regulates mesothelioma proliferation and invasiveness
W-B Ou et al.
ONCOGENE (2011)
Targeted Inhibition of Multiple Receptor Tyrosine Kinases in Mesothelioma
Wen-Bin Ou et al.
NEOPLASIA (2011)
Integrated Profiling Reveals a Global Correlation between Epigenetic and Genetic Alterations in Mesothelioma
Brock C. Christensen et al.
CANCER RESEARCH (2010)
Merlin, a Magic Linker Between the Extracellular Cues and Intracellular Signaling Pathways that Regulate Cell Motility, Proliferation, and Survival
Ivan Stamenkovic et al.
CURRENT PROTEIN & PEPTIDE SCIENCE (2010)
Knockdown of COPA, Identified by Loss-of-Function Screen, Induces Apoptosis and Suppresses Tumor Growth in Mesothelioma Mouse Model
Hitomi Sudo et al.
GENOMICS (2010)
Malignant pleural mesothelioma: Genome-wide expression patterns reflecting general resistance mechanisms and a proposal of novel targets
Oluf Dimitri Roe et al.
LUNG CANCER (2010)
Estrogen Receptor β Exerts Tumor Repressive Functions in Human Malignant Pleural Mesothelioma via EGFR Inactivation and Affects Response to Gefitinib
Giulia Pinton et al.
PLOS ONE (2010)
Frequent Mutation of BAP1 in Metastasizing Uveal Melanomas
J. William Harbour et al.
SCIENCE (2010)
Identification of Potential Therapeutic Targets in Malignant Mesothelioma Using Cell-Cycle Gene Expression Analysis
Solange Romagnoli et al.
AMERICAN JOURNAL OF PATHOLOGY (2009)
Epigenetic Profiles Distinguish Malignant Pleural Mesothelioma from Lung Adenocarcinoma
Yasuhiro Goto et al.
CANCER RESEARCH (2009)
Epigenetic Profiles Distinguish Pleural Mesothelioma from Normal Pleura and Predict Lung Asbestos Burden and Clinical Outcome
Brock C. Christensen et al.
CANCER RESEARCH (2009)
Molecular Targets in Malignant Pleural Mesothelioma Treatment
Giulia Pasello et al.
CURRENT DRUG TARGETS (2009)
The basics of epithelial-mesenchymal transition
Raghu Kalluri et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
Malignant Pleural Mesothelioma
Anne S. Tsao et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Activation of the PI3K-AKT pathway in human malignant mesothelioma cells
Yutaro Suzuki et al.
MOLECULAR MEDICINE REPORTS (2009)
Functional inactivation of NF2/merlin in human mesothelioma
Claudio Thurneysen et al.
LUNG CANCER (2009)
Global Gene Expression Profiling Of Human Pleural Mesotheliomas: Identification of Matrix Metalloproteinase 14 (MMP-14) as Potential Tumour Target
Stefania Crispi et al.
PLOS ONE (2009)
Expression of estrogen receptor beta in the breast carcinoma of BRCA1 mutation carriers
Maria M. Litwiniuk et al.
BMC CANCER (2008)
A conditional mouse model for malignant mesothelioma
Johan Jongsma et al.
CANCER CELL (2008)
Membrane-anchored growth factors, the epidermal growth factor family: Beyond receptor ligands
Shigeki Higashiyama et al.
CANCER SCIENCE (2008)
Somatic mutations affect key pathways in lung adenocarcinoma
Li Ding et al.
NATURE (2008)
Dynamic histone H3 methylation during gene induction: HYPB/Setd2 mediates all H3K36 trimethylation
John W. Edmunds et al.
EMBO JOURNAL (2008)
Phase II study of erlotinib in patients with malignant pleural mesothelioma: A Southwest Oncology Group study
Linda L. Garland et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Immunohistochemical marker panels for distinguishing between epithelioid mesothelioma and lung adenocarcinoma
Kei Kushitani et al.
PATHOLOGY INTERNATIONAL (2007)
Tyrosine kinase mutations in human cancer
Ernst Lengyel et al.
CURRENT MOLECULAR MEDICINE (2007)
A mesothelioma epidemic in Cappadocia: scientific developments and unexpected social outcomes
Michele Carbone et al.
NATURE REVIEWS CANCER (2007)
Gene copy number analysis in malignant pleural mesothelioma using oligonucleotide array CGH
P. M. Lindholm et al.
CYTOGENETIC AND GENOME RESEARCH (2007)
Re-expression of the tumor suppressor NF2/merlin inhibits invasiveness in mesothelioma cells and negatively regulates FAK
P. I. Poulikakos et al.
ONCOGENE (2006)
Genetic predisposition to fiber carcinogenesis causes a mesothelioma epidemic in Turkey
A. Umran Dogan et al.
CANCER RESEARCH (2006)
Expression and prognostic significance of hypoxia-inducible factor 1 alpha (HIF-1 alpha) in malignant pleural mesothelioma (MPM)
A Klabatsa et al.
LUNG CANCER (2006)
Functional analysis of c-Met/hepatocyte growth factor pathway in malignant pleural mesothelioma
R Jagadeeswaran et al.
CANCER RESEARCH (2006)
Divorcing ARF and p53: an unsettled case
Charles J. Sherr
NATURE REVIEWS CANCER (2006)
A mouse model recapitulating molecular features of human mesothelioma
DA Altomare et al.
CANCER RESEARCH (2005)
Mitogen-activated protein kinase expression and activation does not differentiate benign from malignant mesothelial cells
L Vintman et al.
CANCER (2005)
Identification of novel candidate oncogenes and tumor suppressors in malignant pleural mesothelioma using large-scale transcriptional profiling
GJ Gordon et al.
AMERICAN JOURNAL OF PATHOLOGY (2005)
Gefitinib in patients with malignant mesothelioma: A phase II study by the cancer and leukemia group B
R Govindan et al.
CLINICAL CANCER RESEARCH (2005)
Transcription factors as targets for cancer therapy
JE Darnell
NATURE REVIEWS CANCER (2002)
Angiogenesis is an independent prognostic factor in malignant mesothelioma
JG Edwards et al.
BRITISH JOURNAL OF CANCER (2001)
Genetic-susceptibility factor and malignant mesothelioma in the Cappadocian region of Turkey
I Roushdy-Hammady et al.
LANCET (2001)
TGFβ signaling in growth control, cancer, and heritable disorders
J Massagué et al.
CELL (2000)
分享论文
